JPRN-UMIN000004433Recruiting未知
Multi-center randomized study of prophylactic effect of Landiorol for prevention of atrial fibrillation after cardiac surgery. - Prophylactic effect of Landiorol for prevention of atrial fibrillation after cardiac surgery.
Graduate school of medical sciences, Kumamoto University0 sites200 target enrollmentStarted: December 1, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Cardiogenic shock, chronic atrial fibrillation, bronchial asthma, pulmonary hypertension, untreated pheochromocytoma, severe bradycardia including A-V block more than II degree, severe allergy to Landiorol, a judgement of attending physician that patient participation would be inappropriate
Investigators
Similar Trials
Unknown
Not Applicable
Multicenter randomized trial of the prevention of gastric mucosal injury with Rabeprazol in chemotherapeutic cases of pancreatic cancerPancreatic CancerJPRN-UMIN000001316Faculty of Mediceine, University of Tokyo60
Recruiting
Phase 2
Prevention of severe oral mucositis by RINDERON-V Ointment 0.12% during radiotherapy for oral cavity and oropharynx tumorOral cavity and oropharynx tumorOral cavity and oropharynx tumor, oral mucositisJPRN-jRCTs071200013Soutome Sakiko102
Completed
Not Applicable
Increasing physical activity: designing and testing a workplace interventioTopic: Generic Health Relevance and Cross Cutting ThemesSubtopic: Generic Health Relevance (all Subtopics)Disease: Public Health ResearchPhysical activityISRCTN08807396niversity of Leeds (UK)1,300
Active, not recruiting
Not Applicable
Prospective randomized multicenter study to prevent chemotherapy induced ovarian failure with the GnRH-Agonist Goserelin in young hormone insensitive breast cancer patients receiving anthracycline containing (neo-)adjuvant chemotherapy (GBG 37) - Zoro-young hormone insensitive breast cancer patients receiving anthracycline containing (neo-)adjuvant chemotherapyEUCTR2004-003980-62-DEGBG Forschungs GmbH62
Completed
Not Applicable
A prospective randomized multicentre efficacy study on defining the optimal cryoballoon duration therapy for treatment of atrial fibrillation: The 1-2-3 study10007521Atrial FibrillationNL-OMON45131Medisch Spectrum Twente222
